2000

International Conference on Harmonisation; Guidance on Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances.  (29DEC00)
Click here for
txt or pdf
Prepublication display

Agency Information Collection Activities; Submission for OMB Review; Comment Request; Guidance for Industry; Changes to an Approved NDA or ANDA.  (21DEC00)
Click here for
txt or pdf
Prepublication display

Draft ``Guidance for Industry: Variances for Blood Collection from Individuals with Hereditary Hemochromatosis;'' Availability.  (20DEC00)
Click here for
txt or pdf
Prepublication display
Draft Guidance

Draft Guidance for Industry on Labeling OTC Human Drug Products-Submitting Requests for Exemptions and Deferrals; Availability.  (19DEC00)
Click here for
txt or pdf
Prepublication display
Draft Guidance

Guidance for Industry on Labeling Over-the-Counter Human Drug Products Using a Column Format; Availabiliy.  (19DEC00)
Click here for
txt or pdf
Prepublication display
The Guidance

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); Draft Guidance on Safety Studies for Veterinary Drug Residues in Human Food: Reproduction Studies (VICH GL22); Availability; Request for Comments.   (19DEC00)
Click here for
txt or pdf
Prepublication display
Draft Guidance

International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); Draft Guidance for Industry on Safety Studies for Veterinary Drug Residues in Human Food: Genotoxicity Studies (VICH GL23); Availability; Request for Comments.  (18DEC00)
Click here for
txt or pdf
Prepublication display
Draft Guidance

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); Draft Guidance on Pharmacovigilance of Veterinary Medicinal Products: Management of Adverse Event Reports (AER's) (VICH GL24); Availability; Request of Comments.   (18DEC00)
Click here for
txt or pdf
Prepublication display                                                                                                       Draft Guidance

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); Draft Guidances for Industry on Effectiveness of Anthelmintics: Specific Recommendations for Feline (VICH GL20) and Effectiveness of Anthelmintics: Specific Recommendations for Poultry (VICH GL21); Availability; Request for Comments.  (18DEC00)
Click here for
txt or pdf
Prepublication display
Draft Guidance VICH GL20 Recommendations for Feline
Draft Guidance VICH GL21 Recommendations for Poultry

International Conference on Harmonisation; Guidance on E11 Clinical Investigation of Medicinal Products in the Pediatric Population; Availability.  (15DEC00)
Click here for
txt or pdf
Prepublication display
The Guidance

Draft Guidance for Industry on Botanical Drug Products; Availability; Reopening of Comment Period.   (15DEC00)
Click here for
txt or pdf
Prepublication display
Draft Guidance

Agency Information Collection Activities; Announcement of OMB Approval; Guidance for Industry on How to Use E-Mail to Submit Information to the Center for Veterinary Medicine.  (07DEC00)
Click here for
txt or pdf
Prepublication display

Guidance for Industry and for FDA Employees on Import Alert G6 T1# K660966, Detention Without Physical Examination of Active Pharmaceutical Ingredients That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet the Requirements for the Labeling Exemptions in 21 CFR 201.122; Availability.   (04DEC00)
Click here for
txt or pdf
Prepublication display
The Guidance

Draft Guidance for Industry on Recommendations for Complying With the Pediatric Rule (21 CFR 314.55(a) and 601.27(a)); Availability.  (04DEC00)
Click here for
txt or pdf
Prepublication display
The Guidance

Guidance for Industry and FDA Reviewers: Class II Special Control Guidance Document for Anti-Saccharomyces cerevisiae (S. cerevisiae) Antibody (ASCA) Premarket Notifications; Availability. (22NOV00)
Click here for
txt or pdf
Prepublication display
The Guidance

Guidance Documents for Premarket Notification (510(k)) Submissions for Indwelling Blood Gas Analyzers; Availability. (22NOV00)
Click here for
txt or pdf
Prepublication display
The Guidance

Reports and guidance documents; availability, etc.: Carcinogenicity study protocol submissions; correction. (21NOV00)
Click here for
txt or pdf

Guidance for Reviewers: Potency Limits for Standardized Dust Mite and Grass Allergen Vaccines: A Revised Protocol; Availability. (20NOV00)
Click here for
txt or pdf
Prepublication display
The Guidance

Guidance for Industry: Testing Limits in Stability Protocols for Standardized Grass Pollen Extracts; Availability. (20NOV00)
Click here for
txt or pdf
Prepublication display
The Guidance

Draft Guidance for Industry on Refusal of Inspection or Access to HACCP Records Pertaining to the Safe and Sanitary Processing of Fish and Fishery Products; Availability. (14NOV00)
Click here for
txt or pdf
Prepublication display
The Draft Guidance

Medical Devices Draft Guidance on Over the Counter (OTC) Screening Tests for Drugs of Abuse: Guidance for Premarket Notifications; Availability. (14NOV00)
Click here for
txt or pdf
Prepublication display
The Draft Guidance

Medical Devices Draft Guidance on Guidance for Prescription Use Drugs of Abuse Assays Premarket Notifications; Availability. (14NOV00)
Click here for
txt or pdf
Prepublication display
The Draft Guidance

Agency Information Collection Activities; Submission for OMB Review; Comment Request; Draft Guidance for Industry on Information Program on Clinical Trials for Serious or Life-Threatening Diseases: Establishment of a Data Bank. (09NOV00)
Click here for
txt or pdf
Prepublication display

Draft Guidance for Industry on Cancer Drug and Biological Products--Clinical Data in Marketing Applications; Availability. (09NOV00)
Click here for
txt or pdf
Prepublication display
The Draft Guidance

Draft Guidance for Industry on Carcinogenicity Study Protocol Submissions; Availability. (07NOV00)
Click here for
txt or pdf
Prepublication display
The Draft Guidance

Final Guidance for Industry: The Use of Published Literature in Support of New Animal Drug Approval; Availability. (07NOV00)
Click here for
txt or pdf
Prepublication display
The Guidance

Guidance for Industry on Bioavailability and Bioequivalence Studies for Orally Administered Drug Products_General Considerations; Availability. (27OCT00)
Click here for
txt
Prepublication display
The Guidance

Draft Guidance for Industry on Referencing Discontinued Labeling for Listed Drugs in Abbreviated New Drug Applications; Availability. (26OCT00)
Click here for
txt or pdf
Prepublication display
The Draft Guidance

Revised Guidance for Industry on Submitting and Reviewing Complete Responses to Clinical Holds; Availability. (26OCT00)
Click here for
txt or pdf
Prepublication display
The Guidance

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); Draft Guidances for Industry on ``Effectiveness of Anthelmintics: Specific Recommendations for Equine'' (VICH GL15), ``Effectiveness of Anthelmintics: Specific Recommendations for Porcine'' (VICH GL16), and ``Effectiveness of Anthelmintics: Specific Recommendations for Canine'' (VICH GL19); Availability; Request for Comments. (19OCT00)
Click here for
txt or pdf
Prepublication display
Draft Guidance Specific Recommendations for Equine VICH GL15
Draft Guidance Specific Recommendations for Porcine VICH GL16
Draft Guidance Specific Recommendations for Canine VICH GL19

Agency Information Collection Activities; Submission for OMB Review; Comment Request; Public Health Service (PHS) Guideline on Infectious Disease Issues in Xenotransplantation. (18OCT00)
Click here for
txt or pdf
Prepublication display

Guidance for Industry: Supplemental Guidance on Testing for Replication Competent Retrovirus in Retroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors; Availability. (18OCT00)
Click here for
txt or pdf
Prepublication display
The Guidance

Advisory Committee for Pharmaceutical Science; Notice of Meeting. (17OCT00)
Click here for
txt or pdf
Prepublication display
Guidance for  Industry, Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System
Draft Guidance for Industry, BA and BE Studies for Orally Administered Drug Products-General Considerations
Guidance for Industry, Average, Population, and Individual Approaches to Establishing Bioequivalence

Agency Information Collection Activities; Announcement of OMB Approval; Submitting and Reviewing Complete Responses to Clinical Holds; Guidance for Industry. (03OCT00)
Click here for
txt or pdf
Prepublication display
Supporting Statement

Mutual Recognition Agreement, Medical Device Annex; Confidence Building Activities: Availability of Draft Guidances. (03OCT00)
Click here for
txt or pdf
Prepublication display
The Draft Guidance
The Draft Guidance

Draft Guidance for Infant/Child Apnea Monitor 510(k) Submissions; Availability. (22SEP00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit Information to the Center for Veterinary Medicine. (21SEP00)
Click here for
txt or pdf
Prepublication document

Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit a Notice of Intent to Slaughter for Human Food Purposes. (21SEP00)
Click here for
txt or pdf
Prepublication document

Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit a Notice of Final Disposition of Animals Not Intended for Immediate Slaughter. (21SEP00)
Click here for
txt or pdf
Prepublication document

Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit a Notice of Intent to Slaughter for Human Food Purposes. (21SEP00)
Click here for
txt or pdf
Prepublication document

Administrative Practices and Procedures; Good Guidance Practices. (19SEP00)
Click here for
txt or pdf
Prepublication document

Draft Compliance Guidance: The Mammography Quality Standards Act Final Regulations Document 1B4; Availability. (13SEP00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Draft ``Guidance for Industry: Considerations for Reproductive Toxicity Studies for Preventive Vaccines for Infectious Disease Indications;'' Availability. (08SEP00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Draft Guidance for Industry; Special Control Guidance for Premarket Notifications for Totally Implanted Spinal Cord Stimulators for Pain Relief; Availability. (06SEP00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Guidance for Industry on Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System; Availability. (31AUG00)
Click here for
txt or pdf
Prepublication document
The Guidance

Draft Guidance for Industry on Analytical Procedures and Methods Validation: Chemistry, Manufacturing, and Controls Documentation; Availability. (30AUG00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

International Conference on Harmonisation; Draft Guidance on M4 Common Technical Document; Availability. (24AUG00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance Basic Guidance
The Draft Guidance Efficacy
The Draft Guidance Quality
The Draft Guidance Safety

Draft Guidance for Industry on Administrative Procedures for CLIA Categorization; Availability. (14AUG00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Guidance for Industry on Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals; Availability. (14AUG00)
Click here for
txt or pdf
Prepublication document
The Guidance

Draft Guidance for Industry on Surveillance and Detention Without Physical Examination of Condoms; Availability. (14AUG00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Draft Guidance for Industry on Botanical Drug Products; Availability. (11AUG00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Guidance for the Content of Premarket Notifications (510(k)s) for Extracorporeal Shock Wave Lithotripters Indicated for the Fragmentation of Kidney and Ureteral Calculi: Availability. (09AUG00)
Click here for
txt or pdf
Prepublication document
The Guidance

Guidance for Industry and for FDA Reviewers: Guidance on Section 216 of the Food and Drug Administration Modernization Act of 1997; Availability. (09AUG00)
Click here for
txt or pdf
Prepublication document
The Guidance

International Conference on Harmonisation; Draft Guidance on Principles for Clinical Evaluation of New Antihypertensive Drugs; Availability. (09AUG00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

International Conference on Harmonisation; Draft Guidance on Safety Pharmacology Studies for Human Pharmaceuticals; Availability. (07AUG00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Obstetrical and Gynecological Devices; Classification of the Clitoral Engorgement Device.  (02AUG00)
Click here for
txt or pdf
The Guidance Document

International Conference on Harmonisation; Draft Guidance on Good Manufacturing Practice for Active Pharmaceutical Ingredients; Availability. (01AUG00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Draft Guidance for Industry on Refractive Implants: Investigational Device Exemptions (IDE's) and Premarket Approval Applications (PMA's); Availability. (01AUG00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Revised Draft Guidance for Industry on Developing Medical Imaging Drugs and Biologics; Availability. (31JUL00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Medical Devices; Draft Guidance for Surveillance and Detention Without Physical Examination of Surgeons' and/or Patient Examination Gloves; Availability. (26JUL00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Annual Comprehensive List of Guidance Documents at the Food and Drug Administration. (21JUL00)
Click here for
txt or pdf
Prepublication document

International Conference on Harmonisation; Draft Revised Guidance on Impurities in New Drug Substances. (20JUL00)
Click here for
txt or pdf
Prepublication document

International Conference on Harmonisation; Draft Revised Guidance on Impurities in New Drug Products. (19JUL00)
Click here for
txt or pdf
Prepublication document

Blood Standards; Pilot Program for Licensing and Draft Guidance for Industry: CBER Pilot Licensing Program for Immunization of Source Plasma Donors Using Immunogen Red Blood Cells Obtained From an Outside Supplier;'' Availability. (18JUL00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Compliance Guidance: The Mammography Quality Standards Act Final Regulations Document #3; Availability. (18JUL00)
Click here for
txt or pdf
Prepublication document
The Guidance

Guidance for Industry and FDA Reviewers on Medical Device Use--Safety: Incorporating Human Factors Engineering into Risk Management; Availability.18JUL00)
Click here for
txt or pdf
Prepublication document
The Guidance

Medical Devices; Draft Guidance for Staff, Industry, and Third Parties Implementation of Third Party Programs Under the FDA Modernization Act of 1997; Availability. (18JUL00)
Click here for
txt or pdf
Prepublication document

Draft Guidance for Industry: Food-Contact Substance Notification System; Availability. (13JUL00)
Click here for
txt
Prepublication document
The Draft Guidance

Draft Guidance for Industry on Combined Oral Contraceptives--Labeling for Healthcare Providers and Patients; Availability. (10JUL00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Agency Information Collection Activities; Submission for OMB Review; Comment Request; Guidance for Industry: Submitting and Reviewing Complete Responses to Clinical Holds. (05JUL00)
Click here for
txt or pdf
Prepublication document

Draft Guidance for Industry on How to Use E-Mail to Submit a Notice of Final Disposition of Animals Not Intended for Immediate Slaughter; Availability. (29JUN00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Draft Guidance for Industry on How to Use E-Mail to Submit a Notice of Intent to Slaughter for Human Food Purposes; Availability. (29JUN00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Draft Guidance for Industry on How to Use E-Mail to Submit a Request for a Meeting or Teleconference to the Office of New Animal Drug Evaluation; Availability. (29JUN00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Draft Guidance for Industry on How to Use E-Mail to Submit Information to the Center for Veterinary Medicine; Availability. (29JUN00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Final Guidance: Importation of Pasteurized Milk Ordinance (PMO) Defined Dairy Products (M-I-00-4); Availability. (28JUN00)
Click here for
txt or pdf
Prepublication document
The Guidance

Draft Guidance for Industry on Chronic Cutaneous Ulcer and Burn Wounds-Developing Products for Treatment; Availability. (28JUN00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Draft Guidance for Industry on Allergic Rhinitis: Clinical Development Programs for Drug Products; Availability. (21JUN00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Draft Guidance for Industry on the Content and Format of the Adverse Reactions Section of Labeling for Human Prescription Drugs and Biologics; Availability. (21JUN00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance<